Grifols shares drop as buyer Brookfield loses interest - report

Grifols share price dropped by more than a tenth on Wednesday on reports that suitor Brookfield was considering dropping its planned takeover of the Spanish healthcare group.

A report by Reuters cited sources close to the matter suggesting that the Canadian private equity firm might walk away from the deal due to a conflict over Grifols' value.

Brookfield had said in September it was considering an offer jointly with the Grifols family, which own around a third of the company.

However, an announcement by the company on 20 November claimed that Brookfield's €6.45bn indicative offer "significantly undervalues the company’s fundamental prospects and its long-term potential".

Grifols urged shareholders to reject the tentative, non-binding indication, leading to concerns that the Canadian firm could abandon its pursuit.

According to Bloomberg on Wednesday, a Grifols family spokesperson said the family wouldn't support another approach by a third-party to take the company private.

The stock was down nearly 12% at €9.42 by 1029 in Madrid.